The popularity of Sildenafil initially fueled a boom for the drug industry, but recent shifts present a complicated scenario for shareholders. Off-patent competitors are reducing profits, and persistent litigation add https://larissaxqqw332428.post-blogs.com/62032726/viagra-and-pharma-a-volatile-play